Digital Therapeutics in the NHS: The rise of digital therapies & the evidence that proves they work

April 24 2018

Digital therapies are no longer a ‘nice to have’, there is evidence to show how they support patients and clinicians with detection, prevention, wellness and disease management. Acting as digital companions, supporting patients and clinicians with condition management and sensors which feed patients and clinicians important data and insight.

Digital therapies have been proven to reduce the need for acute care in diabetes, asthma, cardiac and pulmonary rehabilitation. There is strong evidence to support their effectiveness in depression and anxiety too, with a further 24 areas showing positive results (IQVIA Institute report).

The truth is, the next blockbuster therapy is probably already in the pocket or purse of your patients and  populations. Their next trip to the doctor could include a prescription for a mobile app in addition to, or instead of, medicine. Are you ready? 

For delegates attending, this event will: 

•  Showcase the evidence that exists right now, supporting the clinical effectiveness of digital therapies

•  Provide delegates the opportunity to see real examples of innovations and interrogate the evidence

•  Co-produce a Toolkit for commissioning and adopting digital therapies with confidence

 

 

“The results have been beyond our expectations. Historically, the education classes on offer for patients with Type 2 diabetes have seen low attendance. There was an excellent uptake of patients completing the trial using the apps. This alongside the clinically significant improvements in HbA1c, blood pressure and weight; show just how well people respond when they can receive support at the click of a button.” 

Dr Tony Willis

Diabetes Clinical Lead, North West London Collaboration of CCGs

Speaker Highlights (updated)

 

Nelia Padilla

Nelia Padilla

Vice President, Global Services Global Lead, Digital Health at IQVIA

‘The Growing Value of Digital Health in the UK’

Sarah Haywood

Sarah Haywood

Chief Executive Officer at MedCity 

Question Time Panel: Shaping a digital therapies toolkit

Jonathan Sheffield

Jonathan Sheffield

CEO at National Institute for Health Research

Where do you start and how do we adopt and take these therapies forward?

Anand Iyer

Anand Iyer

Chief Strategy Officer at WellDoc, Inc.  

One of 5 innovators on the Panel: Interrogating the evidence

Mark Duman

Mark Duman

Patient, Diabetes UK Service Champion

Question Time Panel: Shaping a digital therapies toolkit

Mark Campbell

Mark Campbell

Acting Programme Director – Devices and Diagnostics, National Institute for Health and Care Excellence

Indra Joshi

Indra Joshi

Dr Indra Joshi, Digital Health and AI Clinical Lead (NHS England)

Dr Mark Kelsey GP

Dr Mark Kelsey

GP & Clinical Chair, NHS Southampton City Clinical Commissioning Group

Question Time Panel: Shaping a digital therapies toolkit

Interrogate the evidence of 5 digital therapies proven to work from a patient, clinician, commissioner and policy perspective. Find out how the use of digital health apps in diabetes prevention, diabetes management, asthma, cardiac rehabilitation, mental health, and pulmonary rehabilitation are proven to reduce the need for acute care and  could save the U.K. an estimated £170 million per year while improving the experience and outcomes for patients and populations.

Akili

Akili

The Company’s STARS-ADHD pivotal study of its lead investigational digital medicine, AKL-T01, in paediatric attention-deficit/hyperactivity disorder (ADHD).

Big Health

Big Health

Big Health, creators of Sleepio – an app that helped around 75% of people with persistent sleep problems to improve their sleep to healthy levels.

my mhealth

my mhealth

Creators of myCOPD – proven to correct 98% of inhaler errors (present in over 90% of patients) with no other clinical intervention.

Voluntis

Voluntis

Develop state-of-the-art digital therapeutics to accompany and enhance a specific medication or medical device.

WellDoc

WellDoc

Our clinical evidence shows a mean reduction of 1.7 to 2.0 point A1C drop for individuals living with type 2 diabetes who used BlueStar.

Who should attend?

 

Clinical Directors and Clinicians
  • – See first hand what’s working today and get insight into how digital therapies are changing clinical practice.
  • – Gain a better understanding of the dynamic between digitally driven behaviour change and clinical outcomes.
  • – Learn how you can interrogate digital therapy data to demonstrate patient benefit.
CIOs and CCIOs
  • See and understand the evidence base that will help you deliver your ambitions and get buy-in from your board.
  • – Talk to five digital therapeutic innovators who have found ways to implement their solutions and demonstrate effectiveness.
  • – Move beyond conversations around interoperability and see the real potential of deploying digital therapies in clinical settings.
Commissioners
  • – Understand how you can be confident about commissioning alternative treatment options.
  • – Gain insight into what evidence you should be seeking, how to access it, and what to do when the evidence isn’t there.
  • – See first hand how pioneers in the UK and overseas are developing innovative new ways to commission and evaluate digital therapies.
STP Senior Responsible Officers & Population Health Leads
  • – Learn how proven digital therapy solutions have the potential to simultaneously save the NHS £270 million a year, deliver population health improvements and improve patient experience.
  • – Understand the massive potential of digital therapeutics in areas such as mental health, diabetes, asthma, cardiac rehab etc.
  • – This is your opportunity to see what’s already working and interrogate the evidence of five leading digital therapy providers – to help you understand the evidence you need to be on the lookout for.
Directors and Senior Managers
  • – Digital therapies are changing service delivery already – and they have the potential to be completely transformative. You will need to understand the opportunities and challenges.
  • – The Summit will help you see what’s out there and what’s coming down the track.
  • – It will also help you develop the confidence and foresight to be able to work with your clinicians on testing and implementation.

Last year’s highlights

 

February 2017 marked the one year anniversary of DigitalHealth.London, to mark this milestone we hosted an insight gathering for NHS staff.

DigitalHealth.London/collaborate – ‘Why tomorrow’s patient needs a digital NHS sought to inform and inspire NHS leaders and managers on topical issues relating to digital transformation, including STPs, digital literacy and risk reduction.

 

The Venue

In Marble Arch, with one of the largest panoramic screens in London, set around a beautiful chandelier designed by V&A designer Dave Chihuly, with a galleried balcony overlooking the spacious main hall, the uniquely shaped is the perfect setting for large-scale events.